RA Capital — 2024 Investments

BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.

BiotechHealthtechLongevityRichmond, US

KFKristen Fortney, PhD(Co-Founder, CEO)EMEric Morgen, MD(Co-Founder, COO)KFKristen Fortney(Founder)inEMEric Morgen(Founder)inDGDov Goldstein(Executive Officer)in

BoardPEPatrick Enright(Director)in

Co-investorsANAndreessen HorowitzELElad GilFEFelicis VenturesGRGreen Sands EquityIAIA Seed VenturesLOLongitude Capital+19 more

Monopar Therapeutics is a clinical-stage biotechnology company developing radiopharmaceuticals for oncology and a treatment for Wilson Disease, a rare genetic disorder.

BiotechHealthtechMedical DevicesLake Forest, US

CDChandler D. Robinson(Executive Officer, Director, Promoter)inCMChristopher M. Starr(Executive Officer, Director)Andrew P. Mazar(Executive Officer, Director)

BoardMichael J. Brown(Director)

Co-investorsJAJanus Henderson Investors

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)inAlan Fuhrman(Executive Officer)inTHTodd Harris(President, Chief Executive Officer and Director)inBhavesh Ashar(Chief Operating Officer)in

Co-investorsALAlta PartnersBIBioBritNENextech InvestCACanaan Partners

Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.

BiotechDeep TechMedical DevicesSeattle, US

MLMarc Lajoie(Founder)inSBScott Boyken(Founder)inStanley Riddell(Co-Founder and Scientific Advisor)AFAaron Foster(Executive Officer)inCharity Scripture(Executive Officer)inESEric Soller(Executive Officer)in

Board seatJSJake Simson· per SEC Form D

Co-investorsARArtis VenturesABAbstract VenturesATATEL VenturesATAtinum Investment Co. Ltd.CICivilization Ventures Management, LlcGAGaingels+9 more

Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform.

BiotechDeep TechMedical Devices

George Kassiotis(Co-founder)Drew Pardoll(Co-founder)HAHouman Ashrafian(Co-founder)inKevin Pojasekin

Co-investorsSASamsara BioCapitalSVSV Health InvestorsPFPfizer VenturesDEDementia Discovery FundM M VenturesPFPfizer Venture Investments

MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.

HealthtechMedical DevicesRoboticsJacksonville, US

MTMark Toland(Executive Officer, Director)inAndrew Cleeland(Director)JLJustin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)

Co-investorsANAndera PartnersBIBioStar CapitalDEDeerfield Management CompanyFIFidelity InvestmentsCOCorewell Health VenturesFOFountain Healthcare Partners

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.

BiotechHealthtechPalo Alto, US

LPLuis Pena(President & Chief Executive Officer)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)

Board seatDDDerek DiRocco· per SEC Form D

Co-investorsANAndera PartnersAVAvego BioScience CapitalB B Capital GroupB4B4 CapitalBEBeiersdorf Innovation FundFEFemHealth Ventures+4 more

Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.

BiotechDigital HealthMedical DevicesVancouver, CA

FBFrançois Bénard(Founder)KLKuo-Shyan Lin(Founder)DPDavid Perrin(Founder)

Co-investorsANAndreessen HorowitzASAscenta CapitalDEDelos CapitalFRFrazier Life SciencesGEGeneral CatalystLILightspeed Venture Partners+9 more

AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease.

BiotechHealthtech

Co-investorsAMaMoonDEDelos CapitalBIBiotechnology Value FundSOSoleus Capital

Asher Bio develops selective immunotherapy drugs that target specific immune cell types to promote beneficial effects while minimizing toxicity.

BiotechHealthtechMedical DevicesSan Francisco, US

IDIvana Djuretic(Founder)inAYAndy Yeung(Drug discovery)inYik Andy Yeung(Executive Officer, Director, Promoter)

Co-investorsEMEmles Venture PartnersGOGoAhead VenturesMIMission Bay CapitalMIMission BiocapitalWEWellington ManagementY Y Combinator+9 more

Bluejay is a biotechnology company focused on therapeutic development.

BiotechSan Mateo, US

KCKeting Chu(Founder, Chief Executive Officer and Chairman of the Board)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFRFrazier Life SciencesRIRiverVest Venture PartnersWEWellington ManagementFRFrazier Healthcare PartnersHBHBM Healthcare InvestmentsNONovo Holdings+2 more

DealForma provides a data platform and analyst support for biopharma business development teams to research partnerships, deals, funding trends, and therapeutic areas.

BiotechData & InfrastructureHealthtechSaaS

Chris

Co-investorsTITinySeedALAlgerREREDMILERTRTW Investments L.P.SOSofinnova Ventures

Familiar Machines develops emotionally intelligent physical AI, including the underlying models and hardware, for consumer home use.

AI & Machine LearningConsumerRoboticsWoburn, US

CAColin Angle(CEO & Co-founder)inCJChris Jones(CRDO & Co-founder)inIRIra Renfrew(C2PO & Co-founder)in

Co-investorsDAData Point Capital

Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes.

BiotechFemTechHealthtechMedical DevicesAustin, US

DTDina Turner(Co-founder & Chief Executive Officer)inMVMartin Varsavsky(Co-founder & Chairman)inDRDina Radenkovic(Founder)inMartín Varsavsky(Founder)

BoardDPDusan Perovic(Director)inDMDylan Morris(Director)in

Co-investorsBOBold Capital PartnersDEDeviation CapitalFJFJ LabsFUFuture VenturesGAGaingelsINIngeborg Investments+19 more

IDRX is a regulated stablecoin backed 1:1 by the Indonesian Rupiah, letting users hold and transfer IDR value on blockchain networks for payments, trading, and Web3 financial activity.

Crypto & Web3Fintech

Co-investorsMDMDI VenturesCOCommodore Capital

Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.

BiotechHealthtechMedical DevicesNew York, US

CAClive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)Clive Meanwell(Founder)

Co-investorsALAlpha Wave GlobalARARCH Venture PartnersF-F-Prime CapitalGVGV (Google Ventures)SOSoftBank Vision FundVIViking Global+5 more

Regulus is a Japanese company working on recruiting automation software.

Future of WorkHR Tech

Max Koenig

Co-investors50500 GlobalSISierra VenturesCACanaan Partners IsraelF2F2 Venture CapitalNENew Enterprise Associates (NEA)VIVivo Capital

SeaGen develops automated robots that monitor aquatic ecosystems and remove pollutants while supporting the growth of beneficial species like seaweed to improve food and water security and reduce atmospheric carbon.

CleantechClimate TechRobotics

Co-investorsAEAera VCRIRidgeback CapitalALAlly Bridge GroupT.T. Rowe Price

Synapticure provides virtual care services for individuals and families with neurodegenerative conditions, offering access to expert-led care, cutting-edge treatments, clinical trials, and wraparound support across all 50 US states through a network of local partners.

AI & Machine LearningDigital HealthHealthtechChicago, US

PWPeter Wallach(Founding CEO, Founder)BWBrian Wallach(Founder)inMDMartina de Majo(Founder)inSASandra Abrevaya(Co-Founder, Chief Executive Officer)inJLJason Langheier(Co-Founder, Board Co-Chair)inJHJaimie Hatcher-Martin(Dr.)

Co-investorsGEGeneral AtlanticSVSV AngelB B Capital GroupB4B4 CapitalBEBeaconsfield CapitalCVCVS Health Ventures+15 more

TORL BioTherapeutics develops antibody-drug conjugates (ADCs) targeting Claudin 6 (CLDN6) for the treatment of solid tumors such as ovarian, lung, endometrial, and testicular cancers.

BiotechHealthtechCulver City, US

Dave LicatainAran Maree M.D.inMark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)

Co-investorsOCOCV PartnersCOCowen Healthcare InvestmentsGOGoldman SachsPEPerceptive Xontogeny VentureVEVertex Ventures HC

Vilya designs novel macrocycles using AI and computational biology to create medicines that don't exist in nature.

AI & Machine LearningBiotechDeep Tech

DBDavid Baker(Founder)PSPatrick Salveson, PhD(Co-Founder, CTO)AMAdam Moyer, PhD(Co-Founder, VP of Molecular Design)DBDavid Baker, PhD(Nobel laureate, Co-Founder, Director, IPD UW, Prof. Biochemistry)GBGaurav Bhardwaj, PhD(Co-Founder, UW, Asst. Prof. Medicinal Chemistry)LSLance Stewart, PhD, MBA(Co-Founder, CSO & COO, IPD)

Co-investorsARARCH Venture PartnersMAMadrona Venture GroupMEMenlo VenturesNVNVIDIAALAltitude Ventures Management, LlcALAlumni Ventures+10 more